Related Experiment Videos
[Effective revaccination against tetanus in adults]
Medicinski Pregled
|January 1, 1989
Summary
Tetanus revaccination ensures safe antibody protection, even in older adults with low initial titers. A single vaccine dose rapidly boosts immunity, preventing costly post-injury treatments.
Area of Science:
- Immunology
- Vaccinology
Context:
- Assesses immunologic response to tetanus revaccination in adults.
- Investigates antibody titers and their correlation with age.
Purpose:
- To evaluate the efficacy of tetanus revaccination in achieving protective antibody levels.
- To determine the impact of age and pre-revaccination titers on immune response.
Summary:
- Revaccination rapidly increased antitetanus antibody titers, achieving protective levels (over 1.00 i.j./ml) in all participants within seven days.
- A significant negative correlation exists between patient age and pre-revaccination antibody titers (p < 0.001).
- Post-revaccination titers strongly correlated with pre-revaccination levels (p < 0.001).
Impact:
- Confirms that tetanus revaccination provides prompt and safe protection, even in individuals with low baseline antibody levels.
- Highlights the importance of continued tetanus immunization throughout adulthood.
- Suggests that effective revaccination can reduce the need for expensive active-passive treatments after injury.